Risk Of Developing Liver Cancer After HCV Treatment

▼
Showing posts with label HBV/HCV dual infection. Show all posts
Showing posts with label HBV/HCV dual infection. Show all posts
Friday, May 4, 2018

Hepatitis B and C coinfection in a real-life setting: viral interactions and treatment issues

›
Ann Gastroenterol. 2018 May-Jun;31(3):365-370. doi: 10.20524/aog.2018.0255. Epub 2018 Mar 28. Hepatitis B and C coinfection in a real-...
Friday, February 2, 2018

Hep B reactivation common during direct-acting antiviral therapy for hep C

›
Reuters Health Hep B reactivation common during direct-acting antiviral therapy for hep C Last Updated: 2018-02-02 By Will Boggs MD N...
Wednesday, January 24, 2018

Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C–Infected Patients in the United States

›
Article in Press Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C–Infected Patients in the Unit...
Tuesday, January 23, 2018

Risks for Hepatitis B Reactivation with Newer Hep C Treatments Detailed

›
Medical News | PHYSICIAN'S FIRST WATCH January 22, 2018 Risks for Hepatitis B Reactivation with Newer Hep C Treatments Detailed By Amy ...
Tuesday, November 14, 2017

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences

›
Alimentary Pharmacology & Therapeutics The negative impact of HBV/HCV coinfection on cirrhosis and its consequences Summary Source ...
Monday, June 19, 2017

Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation

›
Volume 46, Issue 2 July 2017  Page 208 Alimentary Pharmacology & Therapeutics LETTERS TO THE EDITORS ...
Tuesday, April 25, 2017

Hepatitis B Virus Reactivation Associated With Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus

›
No Consistent Pattern of HBV Reactivation With Direct-acting Antivirals for HCV NEW YORK ( Reuters Health ) - The largest case review to d...
Friday, April 21, 2017

Gilead Announces Scientific Presentations Demonstrating Efficacy of Harvoni® in Special Patient Populations With HCV Infection

›
Gilead Announces Scientific Presentations Demonstrating Efficacy of Harvoni® (Ledipasvir/Sofosbuvir) in Special Patient Populations With HCV...
Wednesday, February 1, 2017

How Dual Hepatitis B, C Infection Differs from Single Infection

›
How Dual Hepatitis B, C Infection Differs from Single Infection Feb 01, 2017 | Dava Stewart The bodies of patients infected with bot...